RxDoctor Payments Data

John Sanders, MD

Infectious Disease · Winston Salem, NCNPI 1437134095

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $123 of the $149 with a category attached, or 82.7%. Scynexis, Inc. accounts for 82.7% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for infectious disease clinicians in NC, where the typical reported total is $262.

$149in general payments, 2019–2025

Across 2 payments — averaging $74.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scynexis, Inc.$123
  • Merck$26
$5,200,372in research payments, 2019–2025

Across 249 payments — averaging $20,885 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$4.7M
  • Pfizer$427K
  • Astellas Pharma Global Development$48K

What the payments were for

  • Food & beverage$12383%
  • Education$2617%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Scynexis, Inc.1$123
Merck1$26

How this compares

$149 in reported general payments places this provider in the 40th percentile of 250 infectious disease providers in North Carolina.

See all infectious disease providers in North Carolina

Medicare billing

Part B allowed, 2024
$14,659
Medicare patients
83
Services billed
122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →